HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
about
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policiesA sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasmaAdvantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing ProcessDetection of protease activities by flash chronopotentiometry using a reversible polycation-sensitive polymeric membrane electrode.Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural BurundiInfluence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions.Dried blood spots: concepts, present status, and future perspectives in bioanalysis.Therapeutic drug monitoring by dried blood spot: progress to date and future directions.The use of mass spectrometry to analyze dried blood spots.A critical review of properties of darunavir and analytical methods for its determination.How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.Stability-indicating HPLC method for the determination of darunavir ethanolate.Direct injection HILIC-MS/MS analysis of darunavir in rat plasma applying supported liquid extraction.Validation of simultaneous quantitative method of HIV protease inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS/MS.DBS–LC–MS/MS assay for caffeine: validation and neonatal applicationStability Study of Darunavir Ethanolate Tablets Applying a New Stability-Indicating HPLC Method
P2860
Q26786887-E88D5872-FD73-456F-9336-B5934326E9FEQ28533657-04C8E49E-AEAD-439A-94E0-9A1B614B8E7BQ29109543-D4E7DE08-686A-4059-8B16-9DA1A18869C6Q35074826-7F346791-1515-4F31-8A0A-8351E94EE0F6Q35557440-58BE4435-8E03-4ED0-A7A4-B96BAA3F2423Q36087985-ECAA643A-7CD2-461E-9D25-AD3F4FDFFC62Q38128343-470969EE-926C-4A6F-9DA6-A992A569D7F0Q38201371-0B432C8D-4E09-4EDC-9413-DF48C824FF60Q38247481-2D114221-D275-4C5F-B209-CDAE6BB68EAFQ38253959-AB93270F-551D-432C-BBCD-E8F3D511628EQ38267642-FB2929D9-3448-47F4-94A9-A4FA37ED4147Q44748393-C9BBC275-507A-4B64-A020-DC241BC034E1Q46474927-7CE63268-4338-4523-A1C1-85F607D39555Q46826514-A0F592D3-D7E2-4630-B01C-7951BD2E1750Q50091565-AFC06E2C-A024-4B80-9E6E-E761A2A4E3D2Q51848081-BA492503-D2EC-479C-9554-BF581ED87219Q57728095-0CB9B53D-B064-4C6F-8672-52FD0D477579Q58920852-C1DA4059-4CE5-44DA-AE6B-2BF1B06572E3
P2860
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
HPLC-MS method for the quantif ...... ility in different conditions.
@en
HPLC-MS method for the quantif ...... ility in different conditions.
@nl
type
label
HPLC-MS method for the quantif ...... ility in different conditions.
@en
HPLC-MS method for the quantif ...... ility in different conditions.
@nl
prefLabel
HPLC-MS method for the quantif ...... ility in different conditions.
@en
HPLC-MS method for the quantif ...... ility in different conditions.
@nl
P2093
P1476
HPLC-MS method for the quantif ...... ility in different conditions.
@en
P2093
Giovanni Di Perri
Lorena Baietto
Marco Simiele
Mauro Sciandra
Stefano Bonora
P304
P356
10.1016/J.JPBA.2010.02.026
P577
2010-02-25T00:00:00Z